HomepageSTAR • NSE
add
Strides Pharma Science Ltd
Vorige slotkoers
₹ 577,20
Dag-range
₹ 531,20 - ₹ 590,00
Jaar-range
₹ 324,70 - ₹ 804,00
Beurswaarde
51,97Â mld. INR
Gem. volume
645,98K
Koers/winst
22,42
Dividendrendement
0,44%
Primaire beurs
NSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(INR) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 12,01Â mld. | 20,18% |
Bedrijfskosten | 5,18Â mld. | 6,06% |
Netto inkomsten | 932,32Â mln. | 170,98% |
Netto winstmarge | 7,76 | 159,06% |
Winst per aandeel | — | — |
EBITDA | 2,35Â mld. | 53,62% |
Effectief belastingtarief | 18,46% | — |
Balans
Totale activa
Totale passiva
(INR) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 2,47Â mld. | -24,31% |
Totale activa | 59,90Â mld. | -5,49% |
Totale passiva | 37,75Â mld. | -13,11% |
Totaal aandelenvermogen | 22,15 mld. | — |
Uitstaande aandelen | 91,94 mln. | — |
Koers-boekwaardeverhouding | 2,34 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 10,17% | — |
Kasstroom
Nettomutatie in liquide middelen
(INR) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 932,32Â mln. | 170,98% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Opgericht
1990
Hoofdvestiging
Website
Werknemers
3.065